Factors Predicting Ictal Quality in Bilateral Electroconvulsive Therapy Sessions.

bilateral ECT electroconvulsive therapy (ECT) electroencephalography hyperventilation ictal adequacy oxygen postictal suppression regression analysis seizure quality treatment outcome

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
12 Jun 2021
Historique:
received: 26 04 2021
revised: 04 06 2021
accepted: 10 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

In electroconvulsive therapy (ECT), ictal characteristics predict treatment response and can be modified by changes in seizure threshold and in the ECT technique. We aimed to study the impact of ECT procedure-related variables that interact during each session and might influence the seizure results. Two hundred and fifty sessions of bilateral ECT in forty-seven subjects were included. Seizure results were evaluated by two different scales of combined ictal EEG parameters (seizure quality index (SQI) and seizure adequacy markers sum (SAMS) scores) and postictal suppression rating. Repeated measurement regression analyses were performed to identify predictors of each session's three outcome variables. Univariate models identified age, physical status, hyperventilation, basal oxygen saturation, days between sessions, benzodiazepines, lithium, and tricyclic antidepressants as predictors of seizure quality. Days elapsed between sessions, higher oxygen saturation and protocolized hyperventilation application were significant predictors of better seizure quality in both scales used in multivariate models. Additionally, lower ASA classification influenced SQI scores as well as benzodiazepine use and lithium daily doses were predictors of SAMS scores. Higher muscle relaxant doses and lower applied stimulus intensities significantly influenced the postictal suppression rating. The study found several modifiable procedural factors that impacted the obtained seizure characteristics; they could be adjusted to optimize ECT session results.

Identifiants

pubmed: 34204783
pii: brainsci11060781
doi: 10.3390/brainsci11060781
pmc: PMC8231613
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Am J Psychiatry. 1980 Nov;137(11):1416-8
pubmed: 6776828
Am J Psychiatry. 1990 Aug;147(8):1029-35
pubmed: 2375437
J ECT. 2014 Dec;30(4):e39-40
pubmed: 25010034
Acta Psychiatr Scand. 2019 Sep;140(3):196-204
pubmed: 31334829
Arch Gen Psychiatry. 1987 Apr;44(4):355-60
pubmed: 3566457
Convuls Ther. 1993;9(4):262-273
pubmed: 11941222
Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):819-830
pubmed: 29876649
Lancet. 2003 Mar 8;361(9360):799-808
pubmed: 12642045
Gen Hosp Psychiatry. 2018 Jan - Feb;50:54-62
pubmed: 29054017
J Affect Disord. 2012 Apr;138(1-2):1-8
pubmed: 21501875
J Affect Disord. 2018 Apr 15;231:41-43
pubmed: 29428352
Aust N Z J Psychiatry. 2003 Jun;37(3):312-8
pubmed: 12780470
Neuropsychiatr Dis Treat. 2016 Apr 19;12:931-9
pubmed: 27143894
J Affect Disord. 2019 Jun 1;252:135-140
pubmed: 30981950
Br J Anaesth. 1988 Nov;61(5):593-7
pubmed: 3207530
Acta Psychiatr Scand. 2014 Jun;129(6):417-26
pubmed: 24571807
J Clin Psychiatry. 2010 Jun;71(6):775-7
pubmed: 20051218
J ECT. 2014 Dec;30(4):287-91
pubmed: 24625713
Pharmacopsychiatry. 2013 Jun;46(4):147-50
pubmed: 23359338
Brain Stimul. 2016 Jan-Feb;9(1):72-7
pubmed: 26452698
Acta Psychiatr Scand. 2019 Sep;140(3):187-188
pubmed: 31400004
J ECT. 2007 Mar;23(1):14-6
pubmed: 17435566
J Affect Disord. 2017 Aug 1;217:225-232
pubmed: 28431383
Eur Arch Psychiatry Clin Neurosci. 2011 Nov;261 Suppl 2:S172-6
pubmed: 21901267
J ECT. 2018 Jun;34(2):87-94
pubmed: 29461332
Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):831-838
pubmed: 30022318
Am J Psychiatry. 1987 Nov;144(11):1449-55
pubmed: 3314538
J Affect Disord. 2013 Sep 5;150(2):686-90
pubmed: 23668903
Psychiatry Clin Neurosci. 2007 Apr;61(2):168-73
pubmed: 17362434
AMIA Jt Summits Transl Sci Proc. 2019 May 06;2019:672-679
pubmed: 31259023
J Neuropsychiatry Clin Neurosci. 1998 Spring;10(2):178-86
pubmed: 9608406
Acta Psychiatr Neurol Scand. 1956;31(1):61-70
pubmed: 13326498
N Engl J Med. 1993 Mar 25;328(12):839-46
pubmed: 8441428
J ECT. 2006 Sep;22(3):213-7
pubmed: 16957539
Neuropsychopharmacology. 2004 Apr;29(4):813-25
pubmed: 14735129
J ECT. 2016 Jun;32(2):88-92
pubmed: 26397151
Eur Arch Psychiatry Clin Neurosci. 2013 Mar;263(2):167-75
pubmed: 22797771
J ECT. 2018 Mar;34(1):7-13
pubmed: 28658011
J ECT. 2017 Mar;33(1):4-6
pubmed: 28072658
J Neuropsychiatry Clin Neurosci. 1995 Summer;7(3):295-303
pubmed: 7580187
Eur Arch Psychiatry Clin Neurosci. 2017 Dec;267(8):795-801
pubmed: 28401340
Am J Psychiatry. 1953 Aug;110(2):115-8
pubmed: 13065524
Eur Arch Psychiatry Clin Neurosci. 2019 Oct;269(7):859-865
pubmed: 30535616
Eur Arch Psychiatry Clin Neurosci. 1996;246(3):155-64
pubmed: 8739401
Brain Stimul. 2020 Mar - Apr;13(2):450-456
pubmed: 31889671
J ECT. 2014 Dec;30(4):e39
pubmed: 25010030
J ECT. 2019 Sep;35(3):184-188
pubmed: 30720551
J ECT. 2014 Sep;30(3):210-5
pubmed: 24820943
J ECT. 2017 Sep;33(3):167-175
pubmed: 28640168
Acta Psychiatr Scand. 1996 Aug;94(2):101-4
pubmed: 8883570
Eur Arch Psychiatry Clin Neurosci. 2014 Apr;264(3):255-61
pubmed: 23835527
Biol Psychiatry. 1993 Sep 1;34(5):321-30
pubmed: 8399832
J Affect Disord. 1996 Nov 4;41(1):55-8
pubmed: 8938205
World J Biol Psychiatry. 2009;10(4 Pt 3):836-45
pubmed: 19995220
J ECT. 2017 Dec;33(4):237-242
pubmed: 28767528
J Affect Disord. 2010 Dec;127(1-3):66-70
pubmed: 20557948
Rev Psiquiatr Salud Ment. 2017 Jan - Mar;10(1):21-27
pubmed: 27311640
Psychiatr Clin North Am. 1991 Dec;14(4):803-43
pubmed: 1771150

Auteurs

Aida de Arriba-Arnau (A)

Neurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge-ICS, 08907 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, 28029 Madrid, Spain.

Antonia Dalmau Llitjos (A)

Department of Anesthesiology, Reanimation and Pain Clinic, Bellvitge University Hospital-ICS, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Department of Clinical Sciences, School of Medicine, Faculty of Medicine and Health Sciences, Campus Bellvitge, Universitat de Barcelona (UB), 08907 Barcelona, Spain.

Virginia Soria (V)

Neurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge-ICS, 08907 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, 28029 Madrid, Spain.
Department of Clinical Sciences, School of Medicine, Faculty of Medicine and Health Sciences, Campus Bellvitge, Universitat de Barcelona (UB), 08907 Barcelona, Spain.

Stelania Savino (S)

Department of Anesthesiology, Reanimation and Pain Clinic, Bellvitge University Hospital-ICS, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.

Neus Salvat-Pujol (N)

Neurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge-ICS, 08907 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, 28029 Madrid, Spain.
Department of Mental Health, Corporació Sanitària Parc Taulí, 08208 Sabadell, Spain.

Jordi Curto (J)

Department of Public Health, Mental Health and Perinatal Nursing, School of Nursing, Faculty of Medicine and Health Sciences, Campus Bellvitge, Universitat de Barcelona (UB), 08907 Barcelona, Spain.

José Manuel Menchón (JM)

Neurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge-ICS, 08907 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, 28029 Madrid, Spain.
Department of Clinical Sciences, School of Medicine, Faculty of Medicine and Health Sciences, Campus Bellvitge, Universitat de Barcelona (UB), 08907 Barcelona, Spain.

Mikel Urretavizcaya (M)

Neurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge-ICS, 08907 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, 28029 Madrid, Spain.
Department of Clinical Sciences, School of Medicine, Faculty of Medicine and Health Sciences, Campus Bellvitge, Universitat de Barcelona (UB), 08907 Barcelona, Spain.

Classifications MeSH